Skip to main content
Key Specialties
Cardiology Diabetology Endocrinology Gastroenterology Geriatrics and Gerontology Gynecology and Obstetrics Hematology Infectious Disease Internal Medicine Nephrology Neurology Oncology Pediatrics Respiratory Medicine Rheumatology Surgery
Congress Coverage
2024 ACC Congress 2023 ESMO Congress 2023 EASD Congress 2023 ERS Congress 2023 ESC Congress
Clinical Collections
Advances in Alzheimer’s

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.
ADVANCED SEARCH
Log in
Top
Journal of General Internal Medicine
Published in: Journal of General Internal Medicine 10/1998

01-10-1998 | Original Articles

Effect of evaluator and resident gender on the American board of internal medicine evaluation scores

Authors: Dr. Victoria E. Rand, MD, Esther S. Hudes, PhD, MPH, Warren S. Browner, MD, MPH, Robert M. Wachter, MD, Andrew L. Avins, MD, MPH

Published in: Journal of General Internal Medicine | Issue 10/1998

Login to get access
Metadata
Title
Effect of evaluator and resident gender on the American board of internal medicine evaluation scores
Authors
Dr. Victoria E. Rand, MD
Esther S. Hudes, PhD, MPH
Warren S. Browner, MD, MPH
Robert M. Wachter, MD
Andrew L. Avins, MD, MPH
Publication date
01-10-1998
Publisher
Springer-Verlag
Published in
Journal of General Internal Medicine / Issue 10/1998
Print ISSN: 0884-8734
Electronic ISSN: 1525-1497
DOI
https://doi.org/10.1046/j.1525-1497.1998.00202.x

Other articles of this Issue 10/1998

Journal of General Internal Medicine 10/1998 Go to the issue

Announcement

Announcement

Original Articles

Effect of local standards on the implementation of national guidelines for asthma

Reflections

Thoughts in medical school

Original Articles

The effectiveness of cost-effectiveness analysis in containing costs

Editorials

Practice guidelines for practicing doctors

Reflections

Sewing lessens
Obesity Clinical Trial Summary

At a glance: The STEP trials

Read more

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine

Highlights from the ACC 2024 Congress

Year in Review: Pediatric cardiology

Pediatric Cardiology Video

Watch Dr. Anne Marie Valente present the last year's highlights in pediatric and congenital heart disease in the official ACC.24 Year in Review session.

Year in Review: Pulmonary vascular disease

Cardiopulmonary Comorbidity Video

The last year's highlights in pulmonary vascular disease are presented by Dr. Jane Leopold in this official video from ACC.24.

Year in Review: Valvular heart disease

Valvular Heart Disease Video

Watch Prof. William Zoghbi present the last year's highlights in valvular heart disease from the official ACC.24 Year in Review session.

Year in Review: Heart failure and cardiomyopathies

Heart Failure Video

Watch this official video from ACC.24. Dr. Biykem Bozkurt discusses last year's major advances in heart failure and cardiomyopathies.

ACC 2024 Congress Coverage

Year in Review: Heart failure and cardiomyopathies

Heart Failure Video

Watch this official video from ACC.24. Dr. Biykem Bozkurt discusses last year's major advances in heart failure and cardiomyopathies.

Watch now

Semaglutide benefits people with type 2 diabetes and obesity-related heart failure

16-04-2024 Type 2 Diabetes News

Incentivised to exercise

11-04-2024 Lifestyle Modifications News

New intervention for STEMI-related cardiogenic shock

10-04-2024 Myocardial Infarction News

» View more highlights on the ACC 2024 congress hub page

Image Credits